AgeX Therapeutics Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
AgeX Therapeutics General Information
Description
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. The company's product pipeline includes two cell-based and two iTR-based product candidates in development. Its lead cell-based therapeutic candidates in development are AGEX-BAT1 and AGEX-VASC1. Its lead small molecule drug-based therapeutic candidate for iTRTM in discovery is AGEX-iTR1547.
Contact Information
Website
www.agexinc.comCorporate Office
- 1010 Atlantic Avenue
- Suite 102
- Alameda, CA 94501
- United States
Corporate Office
- 1010 Atlantic Avenue
- Suite 102
- Alameda, CA 94501
- United States
AgeX Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 26-Mar-2024 | Completed | Generating Revenue | |||
| 5. IPO | 29-Nov-2018 | Completed | Generating Revenue | |||
| 4. Merger/Acquisition | 08-Nov-2018 | Completed | Startup | |||
| 3. Grant | 02-May-2018 | Completed | Startup | |||
| 2. Grant | 15-Apr-2018 | $11.1M | $10.8M | Completed | Startup | |
| 1. Early Stage VC | 02-Aug-2017 | $10.8M | $10.8M | Completed | Startup |
AgeX Therapeutics Comparisons
Industry
Financing
Details
AgeX Therapeutics Competitors (43)
One of AgeX Therapeutics’s 43 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Barinthus Biotherapeutics | Formerly VC-backed | Altrincham, United Kingdom | ||||
| Mesoblast | Corporation | Melbourne, Australia |
AgeX Therapeutics Signals
AgeX Therapeutics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IBS Capital | Hedge Fund | Minority | ||
| Angel (individual) | Minority | |||
| Juvenescence | VC-Backed Company | Majority | ||
| Kizoo Technology Capital | Venture Capital | Minority | ||
| National Institutes of Neurological Disorders and Stroke | Government |
AgeX Therapeutics Investments & Acquisitions (2)
AgeX Therapeutics’s most recent deal was a Reverse Merger with Serina Therapeutics for . The deal was made on 26-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Serina Therapeutics | 26-Mar-2024 | Reverse Merger | Drug Discovery | ||
| Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) | 16-Aug-2019 | Corporate Asset Purchase | Buildings and Property |
AgeX Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
AgeX Therapeutics FAQs
-
When was AgeX Therapeutics founded?
AgeX Therapeutics was founded in 2017.
-
Where is AgeX Therapeutics headquartered?
AgeX Therapeutics is headquartered in Alameda, CA.
-
What is the size of AgeX Therapeutics?
AgeX Therapeutics has 9 total employees.
-
What industry is AgeX Therapeutics in?
AgeX Therapeutics’s primary industry is Drug Discovery.
-
Is AgeX Therapeutics a private or public company?
AgeX Therapeutics is a Private company.
-
What is AgeX Therapeutics’s current revenue?
The current revenue for AgeX Therapeutics is .
-
How much funding has AgeX Therapeutics raised over time?
AgeX Therapeutics has raised $10.8M.
-
Who are AgeX Therapeutics’s investors?
IBS Capital, , Juvenescence, Kizoo Technology Capital, and National Institutes of Neurological Disorders and Stroke have invested in AgeX Therapeutics.
-
Who are AgeX Therapeutics’s competitors?
Inovio Pharmaceuticals, Capricor Therapeutics, Sangamo Therapeutics, Barinthus Biotherapeutics, and Mesoblast are some of the 43 competitors of AgeX Therapeutics.
-
When was AgeX Therapeutics acquired?
AgeX Therapeutics was acquired on 26-Mar-2024.
-
Who acquired AgeX Therapeutics?
AgeX Therapeutics was acquired by Serina Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process